Literature DB >> 21314333

Mice lacking MSK1 and MSK2 show reduced skin tumor development in a two-stage chemical carcinogenesis model.

Simon Chang1, Lars Iversen, Knud Kragballe, J Simon C Arthur, Claus Johansen.   

Abstract

UNLABELLED: Mitogen- and stress-activated protein kinase (MSK)1/2 are two kinases involved in inflammation as well as in cell transformation.
PURPOSE: To examine the role of MSK1/2 in skin tumor development.
RESULTS: MSK1/2 knockout mice developed significantly fewer skin tumors compared with wild-type mice. The myeloperoxidase activity in TPA-treated skin from MSK1/2 knockout mice was significantly elevated compared with wild-type mice. Furthermore, the mRNA and protein levels of IL-1β as well as the mRNA expression of TNF-α were significantly increased in MSK1/2 knockout mice.
CONCLUSION: These data provide in vivo evidence that MSK1/2 signaling represents a novel tumor-promoting axis in skin carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21314333     DOI: 10.3109/07357907.2010.550594

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  13 in total

1.  Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer.

Authors:  Ke Yao; Hanyong Chen; Kangdong Liu; Alyssa Langfald; Ge Yang; Yi Zhang; Dong Hoon Yu; Myoung Ok Kim; Mee-Hyun Lee; Haitao Li; Ki Beom Bae; Hong-Gyum Kim; Wei-Ya Ma; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2014-07-03

2.  A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1.

Authors:  Haidan Liu; Joonsung Hwang; Wei Li; Tae Woong Choi; Kangdong Liu; Zunnan Huang; Jae-Hyuk Jang; N R Thimmegowda; Ki Won Lee; In-Ja Ryoo; Jong-Seog Ahn; Ann M Bode; Xinmin Zhou; Yifeng Yang; Raymond L Erikson; Bo-Yeon Kim; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2013-10-29

3.  The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling.

Authors:  Atanu Chakraborty; Markus E Diefenbacher; Anastasia Mylona; Olivier Kassel; Axel Behrens
Journal:  Nat Commun       Date:  2015-04-08       Impact factor: 14.919

4.  miR-93 regulates Msk2-mediated chromatin remodelling in diabetic nephropathy.

Authors:  Shawn S Badal; Yin Wang; Jianyin Long; David L Corcoran; Benny H Chang; Luan D Truong; Yashpal S Kanwar; Paul A Overbeek; Farhad R Danesh
Journal:  Nat Commun       Date:  2016-06-28       Impact factor: 14.919

Review 5.  Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer.

Authors:  Jalaj Gupta; Angel R Nebreda
Journal:  FEBS J       Date:  2015-03-16       Impact factor: 5.542

6.  Mitogen- and Stress-Activated Protein Kinase 1 Mediates Alcohol-Upregulated Transcription of Brf1 and tRNA Genes to Cause Phenotypic Alteration.

Authors:  Mingen Lin; Chenghao Huang; Wenfeng Ren; Jun Chen; Ningshao Xia; Shuping Zhong
Journal:  Oxid Med Cell Longev       Date:  2020-06-27       Impact factor: 6.543

7.  Mitogen- and stress-activated protein kinases 1 and 2 are required for maximal trefoil factor 1 induction.

Authors:  Protiti Khan; Bojan Drobic; Beatriz Pérez-Cadahía; Shannon Healy; Shihua He; James R Davie
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

8.  Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes.

Authors:  Binbin Li; Zheng Wan; Guoliang Huang; Zunnan Huang; Xiangning Zhang; Dan Liao; Shengqun Luo; Zhiwei He
Journal:  BMC Cancer       Date:  2015-05-10       Impact factor: 4.430

9.  The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation.

Authors:  Ugo Moens; Sergiy Kostenko; Baldur Sveinbjørnsson
Journal:  Genes (Basel)       Date:  2013-03-26       Impact factor: 4.096

Review 10.  Emerging Roles of the Mitogen and Stress Activated Kinases MSK1 and MSK2.

Authors:  Kathleen M S E Reyskens; J Simon C Arthur
Journal:  Front Cell Dev Biol       Date:  2016-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.